News

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

  • a report discussing how “Coke Morgan Stewart was sworn in as the new Deputy Undersecretary of Commerce for Intellectual Property and Deputy Director of the United States Patent and Trademark Office;”
  • a piece covering how “Trading Technologies (TT) has petitioned the Supreme Court to review a Federal Circuit decision raising three significant questions about patent law and civil procedure;
  • an article reporting how “[t]op Republicans on the House and Senate VA Committees are leading a bill meant to help the Department of Veterans Affairs fire poor-performing employees more quickly;” and
  • a piece describing how the Federal Circuit granted an order “temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis’ blockbuster heart-failure drug Entresto.”

Gene Quinn filed a report for IP Watchdog discussing how “Coke Morgan Stewart was sworn in as the new [Acting] Undersecretary of Commerce for Intellectual Property and [Acting] Director of the United States Patent and Trademark Office.” Quinn covered how Stewart previously served in multiple positions at the USPTO and “has also handled more than 60 Federal Circuit appeals.”

Dennis Crouch wrote a blog post for PatentlyO covering how “Trading Technologies (TT) has petitioned the Supreme Court to review a Federal Circuit decision raising three significant questions about patent law and civil procedure.” Crouch highlighted how the petition for certiorari challenges Fed. R. Civ. P. 60(b)(3) fraud standards, patent eligibility under 35 U.S.C. § 101, and “the Federal Circuit’s handling of patent cases at summary judgment despite disputed factual issues” under Fed. R. Civ. P. 56(a). You can review the docket for the case, Brumfield v. IBG LLC, here on our website.

Jory Heckman penned an article for Federal News Network reporting how “[t]op Republicans on the House and Senate VA Committees are leading a bill meant to help the Department of Veterans Affairs fire poor-performing employees more quickly.” Heckman said VA leadership believes the bill is necessary due to “rulings from the Merit Systems Protection Board, the U.S. Court of Appeals for the Federal Circuit, and the Federal Labor Relations Authority.”

Blake Brittain wrote a piece for Reuters last week describing how the Federal Circuit granted an order “temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis’ blockbuster heart-failure drug Entresto.” Brittain noted how “MSN was preparing to launch its generic on Thursday, the day Novartis’ patent expired.” Notably, the order in question was not released on the Federal Circuit’s website.